Full Text View
Tabular View
No Study Results Posted
Related Studies
The Effects of Fx-1006A on Transthyretin Stabilization and Clinical Outcome Measures in Patients With Non-V30M Transthyretin Amyloidosis
This study is ongoing, but not recruiting participants.
Study NCT00630864   Information provided by FoldRx Pharmaceuticals
First Received: February 27, 2008   Last Updated: February 13, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Amyloidosis
Polyneuropathies
More general conditions related to this trial
Metabolic Diseases
Nervous System Diseases
Neuromuscular Diseases
Peripheral Nervous System Diseases
Interventions listed in this trial
Fx-1006A
Sponsors listed in this trial
FoldRx Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services